Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia
Pediatric Blood & Cancer2005Vol. 45(2), pp. 176–183
Citations Over TimeTop 10% of 2005 papers
James B. Bussel, Stergios Zacharoulis, Kim Kramer, Janice G. McFarland, Joanne Pauliny, Cécile Kaplan, Neonatal Alloimmune Thrombocytopenia Registry Group
Abstract
AIT is a unique type of neonatal thrombocytopenia with significant hemorrhagic consequences. Identification of AIT at the bedside should guide institution of appropriate treatment and lead to serologic testing for confirmation.
Related Papers
- → Prophylactic administration of HPA-1a–specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice(2022)13 cited
- → Provision of Random‐Donor Platelets (HPA‐1a Positive) in Neonatal Alloimmune Thrombocytopenia Due to Anti HPA‐1a Alloantibodies(1996)13 cited
- → Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Br a )(2003)9 cited
- → Neonatal alloimmune thrombocytopenia due to HPA‐9b incompatibility(2009)4 cited
- → Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a(2016)